Global Biosimulation Market 2017 Size, Share, Forecasts to 2022

Published On: Aug 2017

Format: PDF

Publisher: QY Research

Pages: 95

Report ID: 107793

Notes:
Production, means the output of Biosimulation
Revenue, means the sales value of Biosimulation

This report studies the global Biosimulation market, analyzes and researches the Biosimulation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Certara
Simulation Plus
Dassault Systemes
Advanced Chemistry Development
Chemical Computing Group
Entelos
Genedata Ag
Schrodinger
Physiomics
Rhenovia Pharma

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Application, Biosimulation can be split into
Application 1
Application 2


Table of Contents

Global Biosimulation Market Size, Status and Forecast 2022
1 Industry Overview of Biosimulation
1.1 Biosimulation Market Overview
1.1.1 Biosimulation Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biosimulation Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Biosimulation Market by End Users/Application
1.3.1 Application 1
1.3.2 Application 2

2 Global Biosimulation Competition Analysis by Players
2.1 Biosimulation Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Certara
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biosimulation Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Simulation Plus
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biosimulation Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Dassault Systemes
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biosimulation Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Advanced Chemistry Development
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biosimulation Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Chemical Computing Group
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biosimulation Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Entelos
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biosimulation Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Genedata Ag
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biosimulation Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Schrodinger
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biosimulation Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Physiomics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biosimulation Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Rhenovia Pharma
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biosimulation Revenue (Value) (2012-2017)
3.10.5 Recent Developments

4 Global Biosimulation Market Size by Application (2012-2017)
4.1 Global Biosimulation Market Size by Application (2012-2017)
4.2 Potential Application of Biosimulation in Future
4.3 Top Consumer/End Users of Biosimulation

5 United States Biosimulation Development Status and Outlook
5.1 United States Biosimulation Market Size (2012-2017)
5.2 United States Biosimulation Market Size and Market Share by Players (2015-2016)

6 EU Biosimulation Development Status and Outlook
6.1 EU Biosimulation Market Size (2012-2017)
6.2 EU Biosimulation Market Size and Market Share by Players (2015-2016)

7 Japan Biosimulation Development Status and Outlook
7.1 Japan Biosimulation Market Size (2012-2017)
7.2 Japan Biosimulation Market Size and Market Share by Players (2015-2016)

8 China Biosimulation Development Status and Outlook
8.1 China Biosimulation Market Size (2012-2017)
8.2 China Biosimulation Market Size and Market Share by Players (2015-2016)

9 India Biosimulation Development Status and Outlook
9.1 India Biosimulation Market Size (2012-2017)
9.2 India Biosimulation Market Size and Market Share by Players (2015-2016)

10 Southeast Asia Biosimulation Development Status and Outlook
10.1 Southeast Asia Biosimulation Market Size (2012-2017)
10.2 Southeast Asia Biosimulation Market Size and Market Share by Players (2015-2016)

11 Market Forecast by Regions and Application (2017-2022)
11.1 Global Biosimulation Market Size (Value) by Regions (2017-2022)
11.1.1 United States Biosimulation Revenue and Growth Rate (2017-2022)
11.1.2 EU Biosimulation Revenue and Growth Rate (2017-2022)
11.1.3 Japan Biosimulation Revenue and Growth Rate (2017-2022)
11.1.4 China Biosimulation Revenue and Growth Rate (2017-2022)
11.1.5 India Biosimulation Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Biosimulation Revenue and Growth Rate (2017-2022)
11.2 Global Biosimulation Market Size (Value) by Application (2017-2022)
11.3 The Market Drivers in Future

12 Biosimulation Market Dynamics
12.1 Biosimulation Market Opportunities
12.2 Biosimulation Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Biosimulation Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Biosimulation Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source